News
Investors
Investor Summary
Investor Summary
Analysts
FAQ
News & Events
Press Releases
Investor Presentations
IR Calendar
Email Alerts
Stock Info
Quote
Charts
Historical Data
Form 8937
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Governance
Governance Documents
Corporate Responsibility
Corporate Responsibility
Environmental
Social
Governance
Twitter Guidelines
ESG Annual Report
Nasdaq: LGND
Home
Investors
About
Overview
Management Team
Board of Directors
Careers
Contact
Portfolio Summary
Overview
Marketed Products
Portfolio
Royalty Table
Partners and Licensees
Technologies
Overview
OmniAb
Captisol
Pelican Expression Technology Platform
Licensing Opportunities
Business Development
Press Releases
Navigation
Press Releases
Investor Presentations
IR Calendar
Email Alerts
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All News
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Ligand Partner Seelos Therapeutics Becomes a Public Company
January 25, 2019
Ligand to Report Fourth Quarter and Full Year 2018 Results on February 7th
January 15, 2019
« Previous
1
2
3
Twitter
